References
- AdamsKFSchatzkinAHarrisTBOverweight, obesity and mortality in a large prospective chohort of persons 50 to 71 years oldN Engl J Med200635576377816926275
- OgdenCLCarrollMDCurtinLMcDowellMATabakCJFlegalKMPrevalence of overweight and obesity in the United States, 1999–2004JAMA20062951549155516595758
- World Health OrganisationObesity: preventing and managing the global epidemic. Report of a WHO consultationWorld Health Organ Tech Rep Ser2000894ixii1253
- WangYLobsteinTWorldwide trends in childhood overweight and obesityInt J Pediatr Obes20061112517902211
- MustASpadanoJCoakleyEHFieldAEColditzGDietzWHThe disease burden associated with overweight and obesityJAMA19992821523152910546691
- CalleEEThunMJObesity and cancerOncogene2004236365637815322511
- ScaglioneRArganoCDi ChiaraTLicataGObesity and cardiovascular risk: the new public health problem of worldwide proportionsExpert Rev Cardiovasc Ther2004220321215151469
- DespresJPLemieuxIAbdominal obesity and metabolic syndromeNature200644488188717167477
- MenkeAMuntnerPWildmanRPReynoldsKHeJMeasures of adiposity and cardiovascular disease risk factorsObesity20071578579517372330
- FreibergMSPencinaMJD’AgostinoRBLanierKWilsonPWVasanRSBMI vs waist circumference for identifying vascular riskObesity20081646346918239660
- YusufSHawkenSÖunpuuSon behalf of the INTERHEART Study investigatorsEffect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control studyThe Lancet2004364937951
- ThoenesMBramlagePKhanBVSchiefferBKirchWWeirMRAlbuminuria: pathophysiology, epidemiology and clinical relevance of an emerging marker for cardiovascular diseaseFuture Cardiol20073519524
- ParvingHHLehnertHBröchner-MortensenJGomisRAndersenSArnerPIrbesartan in Patients with Type 2 Diabetes and Microalbuminuria Study GroupThe effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetesN Engl J Med20013451287087811565519
- JensenJSFeldt-RasmussenBStrandgaardSSchrollMBorch-JohnsenKArterial hypertension, microalbuminuria, and risk of ischemic heart diseaseHypertension200035489890310775558
- VaurLGueretPLievreMChabaudSPassaPDIABHYCAR Study Group (type 2 DIABetes, Hypertension, CARdiovascular Events and Ramipril) studyDevelopment of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: observations from the DIABHYCAR (type 2 DIABetes, Hypertension, CArdiovascular Events and Ramipril) studyDiabetes Care200326385586012610049
- MimranARibsteinJDu CailarGAngiotensin II receptor antagonists and hypertensionCurr Opin Nephrol Hypertens199983935936310456269
- BöhmMThoenesMDanchinNBramlagePLa PuertaPVolpeMAssociation of cardiovascular risk factors with miroalbuminuria in hypertensive individuals: the i-SEARCH global studyJ Hypertens2007252317232417921828
- LaaksonenDELakkaHMNiskanenLKKaplanGASalonenJTLakkaTAMetabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitionsof the metabolic syndrome in a prospective cohort studyAm J Epidemiol20021561070107712446265
- LakkaHMLaaksonenDELakkaTANiskanenLKKumpusaloETuomilehtoJSalonenJTThe metabolic syndromeand total and cardiovascular disease mortality in middle-aged menJAMA20022882709271612460094
- NinomiyaJKL’ItalienGCriquiMHWhyteJLGamstAChenRSAssociation of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination SurveyCirculation2004109424614676144
- AnandSSIslamSRosengrenAFranzosiMGSteynKYusufaliAHKeltaiMDiazRRangarajanSYusufSon behalf of the INTERHEART InvestigatorsRisk factors for myocardial infarction in women and men: insights from the INTERHEART studyEur Heart J2008297993294018334475
- NielsenSJensenMDRelationship between urinary albumin excretion, body compostion and hyperinsulinemia in nor-motensive glucose-tolerant adultsDiabetes Care1999221728173310526743
- HoffmannISJimenezECubedduLXUrinary albumin excretion in lean, overweight and obese glucose tolerant indiduals: its relationship with dyslipidemia, hyperinsulinemia and blood pressureJ Hum Hypertens20011540741211439316
- YesimTEUgurluSCaglarEBalciHUcgulASarkisCAcbayOGundogduSInvestigation of micro-albuminuria in non-diabetic, nor-motensive obese womenIntern Med2007461963196518084117
- SibleySDThomasWde BoerIBrunzellJDSteffesMWGender and elevated albumin excretion in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort: role of central obesityAm J Kidney Dis20064722323216431251
- De BoerICHSibleySDKestenbaumBDiabetes Control and Complications Trial/Epidemiology of of Diabetes Interventions and Complications Study Research GroupCentral obesity, incident micro-albuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications studyJ Am Soc Nephrol20071823524317151331
- CanoyDBoekholdtMWarehamNBody fat distribution and risk of coronary heart disease in men and women in the european prospective investigation into cancer and nutrition in norfolk cohort. A population-based prospective studyCirculation20071162933294318071080
- McGarryJDBanting lecture 2001: Dysregulation of fatty acidmetabolism in the etiology of type 2 diabetesDiabetes20025171811756317
- BagbySPObesity-initiated metabolic syndrome and the kidney: a receipe for chronic kidney diseaseJ Am Soc Nephrol2004152775279115504931
- SchafferJELipotoxicity: When tissues overeatCurr Opin Lipidol20031428128712840659
- UngerRHOrciLLipoapoptosis: Its mechanism and its diseasesBiochim Biophys Acta2002158520221212531555